Alterity Therapeutics Limited (ASX:ATH)

Intra-Cellular Therapies Revenue

Alterity Therapeutics had revenue of 1.61M AUD in the half year ending December 31, 2024, a decrease of -32.69%. This brings the company's revenue in the last twelve months to 3.72M, up 8.55% year-over-year. In the fiscal year ending June 30, 2024, Alterity Therapeutics had annual revenue of 4.02M with 2.63% growth.

• Revenue (ttm): 3.72M
• Revenue Growth: +8.55%
• P/S Ratio: 34.61
• Revenue / Employee: 372.45K
• Employees: 10
• Market Cap: 128.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.02M	102.95K	2.63%
Jun 30, 2023	3.92M	-1.21M	-23.56%
Jun 30, 2022	5.12M	783.93K	18.06%
Jun 30, 2021	4.34M	-	-
Jun 30, 2020	-	-	-